In addition, approximately 50% of AML patients carrying TP53 mutations and approximately 40% of complex karyotype AML patients displayed chromothripsis, while only 1% of AML with wild-type TP53 and no cases with non-complex karyotype showed this aberration [6,37]. The gene discussed is TP53; the disease is acute myeloid leukemia.